By Robert Roos, Health Editor Mar 11, 2011 (CIDRAP News) – Researchers from the University of Michigan say one measure of flu vaccine efficacy that has been used in a number of past controlled trials is not very accurate, and that this may have led to a degree of overselling of the protection the vaccines […]
Pneumococcal Vaccine: 4 Deaths in Japan, 849 Reported Deaths in United States
By Norma Erickson Japan recently halted the use of two vaccines manufactured by Sanofli Adventis and Pfizer after four young children died. The two types are the Hib vaccine to prevent bacterial meningitis and a vaccine to protect against streptococcus pneumoniae. These vaccines will not be used until investigations are completed to determine whether they are safe. […]
NVIC's "Ask Nurse Vicky" Educates Consumers
NVIC’s “Ask Nurse Vicky March 10, 2011 NVIC’s “Ask Nurse Vicky” Educates Consumers A new online video health education program produced by the National Vaccine Information Center (NVIC) will feature Vicky Debold, RN, PhD, responding to letters from consumers asking questions about vaccination. Since its founding in 1982, NVIC has responded to letters and telephone […]
GSK makes hefty price cuts for Tykerb and Cervarix in India
scripintelligence 10 March 2011 Anju Ghangurde aghangurde@yahoo.com GlaxoSmithKline has enacted significant price cuts for its breast cancer drug Tykerb (lapatinib) and the cervical cancer vaccine Cervarix in the Indian market, as part of its efforts to broaden access to the products through a flexible pricing approach. GSK told Scrip that the price… Read More
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
NEW YORK, March 9, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
http://www.reportlinker.com/p0312154/Cancer-Vaccines—Pipeline-Assessment-and-Market-Forecasts-to-2017.html
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global Cancer vaccines market. The report identifies key trends shaping and driving the global Atopic dermatitis disease market. It also provides insight on the prevalent competitive landscape and the emerging players expected to bring a significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cancer vaccines sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and in house analysis by GlobalData’s team of industry experts.
- « Previous Page
- 1
- …
- 222
- 223
- 224
- 225
- 226
- …
- 393
- Next Page »
